HighTower Advisors’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.9K Hold
4,287
– – ﹤0.01% 3740
2026
Q1
$23.6K Hold
4,287
– – ﹤0.01% 3752
2025
Q4
$113K Hold
4,287
– – ﹤0.01% 3486
2025
Q3
$81.8K Buy
4,287
+44
+1% +$685 ﹤0.01% 3567
2025
Q2
$82.5K Buy
4,243
+833
+24% +$16.2K ﹤0.01% 3499
2025
Q1
$48.7K Buy
3,410
+1,250
+58% +$23.9K ﹤0.01% 3456
2024
Q4
$53.4K Buy
2,160
+910
+73% +$25.4K ﹤0.01% 3450
2024
Q3
$38K Buy
+1,250
New +$48.9K ﹤0.01% 3443

Other funds holding GUTS

HighTower Advisors's GUTS Position: Q2 2026 in Review

HighTower Advisors held its Fractyl Health (GUTS) position steady in Q2 2026 at 4,287 shares worth $40.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3740.

HighTower Advisors first reported a position in GUTS in Q3 2024 and has held it in 8 quarters since. The position peaked at $113K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • HighTower Advisors held 4,287 shares of Fractyl Health worth $40.9K as of Q2 2026.
  • HighTower Advisors left its Fractyl Health share count unchanged in Q2 2026.
  • Fractyl Health made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3740 holding.
  • HighTower Advisors first reported a position in Fractyl Health in Q3 2024 and has held it in 8 quarters since.
  • HighTower Advisors's Fractyl Health position peaked at $113K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.